You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zoster Eye Disease Study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Herpes Zoster Ophthalmicus Trial in Canada, United States (Masked Placebo, Masked Oral Valacyclovir)

Active, not recruiting
  • Herpes Zoster Ophthalmicus
  • Masked Placebo
  • Masked Oral Valacyclovir
  • Birmingham, Alabama
  • +77 more
Jan 17, 2023

Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • Recombinant Herpes Zoster Vaccine
  • Recombinant Herpes Zoster Vaccine Placebo
  • Zhenjiang, Jiangsu, China
    Jiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023

Herpes Zoster Trial in Xinxiang (Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster

Not yet recruiting
  • Herpes Zoster
  • Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +3 more
  • Xinxiang, Henan, China
    Yanjin Center for Disease Control and Prevention
May 4, 2023

Herpes Zoster Trial in Xinxiang (Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster

Active, not recruiting
  • Herpes Zoster
  • Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +5 more
  • Xinxiang, Henan, China
    Yanjin District Center for Disease Control and Prevention
Feb 1, 2023

Herpes Zoster (HZ), Shingles, Infectious Disease Trial in Hollywood, Tampa, Berlin (JCXH-105, Active Control (Shingrix))

Recruiting
  • Herpes Zoster (HZ)
  • +2 more
  • JCXH-105
  • Active Control (Shingrix)
  • Hollywood, Florida
  • +2 more
May 23, 2023

Dry Eye Trial in Gallarate (Rexon-Eye)

Completed
  • Dry Eye
  • Rexon-Eye
  • Gallarate, VA, Italy
    Centro Oculistico Borroni
Nov 3, 2023

Dry Eye Disease Trial in Tehran (Eye mask)

Not yet recruiting
  • Dry Eye Disease
  • Eye mask
  • Tehran, Iran, Islamic Republic of
    Hamideh Sabbaghi
Aug 24, 2023

Dry Eye Disease Trial in Jakarta Pusat (Diquafosol sodium 3%, Sodium hyaluronate 0.1%)

Recruiting
  • Dry Eye Disease
  • Diquafosol sodium 3%
  • Sodium hyaluronate 0.1%
  • Jakarta Pusat, Jakarta, Indonesia
    RSUPN Dr. Cipto Mangunkusumo
Nov 24, 2023

Dry Eye Disease Trial in Beijing (SHR8028 eye drops, Vehicle eye drops.)

Completed
  • Dry Eye Disease
  • SHR8028 eye drops
  • Vehicle eye drops.
  • Beijing, Beijing, China
    Peking University Third Hospital
Apr 24, 2023

Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry

Completed
  • Dry Eye Disease
  • modified hyaluronic acid 0.1% covalently linked to Riboflavin
  • hyaluronic acid 0.1%
  • NAples, Italy
    University of Naples Federico II
Nov 2, 2023

Eyelid Diseases, Eyelid Movement Disorders, Dry Eye Trial in New York (TriLift device)

Not yet recruiting
  • Eyelid Diseases
  • +4 more
  • TriLift device
  • New York, New York
    Manhattan Face and Eye Cosmetic and Orbital Surgery
Jul 11, 2023

Dry Eye Syndromes, Meibomian Gland Dysfunction Trial (Actual IPL, Sham IPL, LLLT)

Not yet recruiting
  • Dry Eye Syndromes
  • Meibomian Gland Dysfunction
  • Actual IPL
  • +2 more
  • (no location specified)
Aug 21, 2023

Dry Eye Disease, Meibomian Gland Dysfunction Trial in Washington (Sunflower Lecithin)

Recruiting
  • Dry Eye Disease
  • Meibomian Gland Dysfunction
  • Sunflower Lecithin
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Sep 22, 2023

Herpes Zoster Trial in Nanjing, Hanzhou (live attenuated zoster vaccine, )

Completed
  • Herpes Zoster
  • live attenuated zoster vaccine
  • placebo
  • Nanjing, Jiangsu, China
  • +1 more
Dec 6, 2021

Varicella Trial in Chuzhou, Lishui, Quzhou (Live attenuated varicella vaccine)

Not yet recruiting
  • Varicella
  • Live attenuated varicella vaccine
  • Chuzhou, Anhui, China
  • +2 more
Jul 12, 2022

Dry Eye Disease: A Cross-Sectional Survey of Real-World Dry Eye

Completed
  • Dry Eye Disease
    • East Hanover, New Jersey
      Novartis
    Aug 25, 2023

    Thyroid Eye Disease, TED Trial in Shanghai (IBI311)

    Recruiting
    • Thyroid Eye Disease, TED
    • Shanghai, Shanghai, China
      Ninth People's Hospital Affiliated to Shanghai Jiao Tong Univers
    Nov 9, 2023

    Meibomian Gland Dysfunction, Dry Eye Disease Trial in Miami, Marlborough, Buenos Aires (Nordlys SWT IPL, Meibomian Gland

    Recruiting
    • Meibomian Gland Dysfunction
    • Dry Eye Disease
    • Nordlys SWT IPL
    • Meibomian Gland Expression (MGX)
    • Miami, Florida
    • +2 more
    Sep 26, 2023

    Mesenchymal Stem Cell, Dry Eye Syndromes Trial (MSCs eye drops)

    Not yet recruiting
    • Mesenchymal Stem Cell
    • Dry Eye Syndromes
    • MSCs eye drops
    • (no location specified)
    Mar 13, 2023

    Dry Eye Disease Trial (Licaminlimab ophthalmic suspension 60 mg/mL, (vehicle of Licaminlimab ophthalmic suspension))

    Not yet recruiting
    • Dry Eye Disease
    • Licaminlimab ophthalmic suspension 60 mg/mL
    • placebo (vehicle of Licaminlimab ophthalmic suspension)
    • (no location specified)
    May 31, 2023

    Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

    Recruiting
    • Thyroid Eye Disease
    • TOUR006 - 20 MG
    • +2 more
    • Miami, Florida
      Site - 0103
    Oct 11, 2023

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Oct 25, 2023

    Croatian Version of Ocular Surface Disease Index Questionnaire

    Active, not recruiting
    • Dry Eye
    • Ocular Surface Disease
    • Questionnaires and dry eye tests
    • Zagreb, Croatia
      University Hospital Sestre milosrdnice
    Jul 9, 2023

    Thyroid Eye Disease Trial (Satralizumab, Placebo)

    Not yet recruiting
    • Thyroid Eye Disease
    • (no location specified)
    Aug 4, 2023

    Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

    Not yet recruiting
    • Dry Eye Disease
    • Topical spironolactone ophthalmic solution, 0.005 mg/cc
    • Placebo
    • Bellaire, Texas
      Richard W Yee, MD PLLC
    Aug 16, 2023